Re: Q1- March 31, 2022 on SEDAR
in response to
by
posted on
May 22, 2022 03:02PM
tada exactly. Don should have bought into the 5-year BOM2 Big Pharma trial assuming what we were told at that time was true. And as you say we'd be well into it and surely the share price would in no way be sitting at 30 cents.
IMO ... Koo